Beneficial Effect of Educational and Nutritional Intervention on the Nutritional Status and Compliance of Gastric Cancer Patients Undergoing Chemotherapy: A Randomized Trial

References

• Jemal A, Center MM, DeSantis C, and Ward EM: Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19, 1893–907, 2010.
   PubMed Web of Science ®Google Scholar
• Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al.: The Global Burden of Cancer 2013. JAMA Oncol 1, 505–27, 2015.
   PubMed Web of Science ®Google Scholar
• Rahman R, Asombang AW, and Ibdah JA: Characteristics of gastric cancer in Asia. World J Gastroenterol 20, 4483–90, 2014.
   PubMed Web of Science ®Google Scholar
• Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, et al.: Treatment of gastric cancer. World J Gastroenterol 20, 1635–49, 2014.
   PubMed Web of Science ®Google Scholar
• Dikken JL, van de Velde CJH, Coit DG, Shah MA, Verheij M, et al.: Treatment of resectable gastric cancer. Therap Adv Gastroenterol 5, 49–69, 2012.
   PubMed Web of Science ®Google Scholar
• Bang Y-J, Kim Y-W, Yang H-K, Chung HC, Park Y-K, et al.: Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet (London, England) 379, 315–21, 2012.
   PubMed Web of Science ®Google Scholar
• Zhao SL, and Fang JY: The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: a meta-analysis. Cancer Invest 26, 317–25, 2008.
   PubMed Web of Science ®Google Scholar
• Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, et al.: Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303, 1729–37, 2010.
   PubMed Web of Science ®Google Scholar
• Liu TS, Wang Y, Chen SY, and Sun YH: An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer. Eur J Surg Oncol 34, 1208–16, 2008.
   PubMed Web of Science ®Google Scholar
• McGough C, Baldwin C, Frost G, and Andreyev HJN: Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer 90, 2278–87, 2004.
   PubMed Web of Science ®Google Scholar
• Inal A, Kaplan MA, Kuçukoner M, Urakci Z, Guven M, et al.: Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study. Asian Pac J Cancer Prev 13, 3869–72, 2012.
   PubMedGoogle Scholar
• Kanagavel D, Pokataev IA, Fedyanin MY, Tryakin AA, Bazin IS, et al.: A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy. Ann Oncol 21, 1779–85, 2010.
   PubMed Web of Science ®Google Scholar
• Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, et al.: ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clin Nutr 25, 245–59, 2006.
   PubMed Web of Science ®Google Scholar
• Poulsen GM, Pedersen LL, Osterlind K, Bæksgaard L, and Andersen JR: Randomized trial of the effects of individual nutritional counseling in cancer patients. Clin Nutr 33, 1–5, 2013.
   PubMed Web of Science ®Google Scholar
• Silvers MA, Savva J, Huggins CE, Truby H, and Haines T: Potential benefits of early nutritional intervention in adults with upper gastrointestinal cancer: a pilot randomised trial. Support Care Cancer 22, 3035–44, 2014.
   PubMed Web of Science ®Google Scholar
• Ravasco P, Monteiro-Grillo I, Vidal PM, and Camilo ME: Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 23, 1431–8, 2005.
   PubMed Web of Science ®Google Scholar
• Ravasco P, Monteiro-Grillo I, and Camilo M: Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy. Am J Clin Nutr 96, 1346–53, 2012.
   PubMed Web of Science ®Google Scholar
• Yesilbalkan OU, Karadakovan A, and Göker E: The effectiveness of nursing education as an intervention to decrease fatigue in Turkish patients receiving chemotherapy. Oncol Nurs Forum 36, E215–22, 2009.
   PubMed Web of Science ®Google Scholar
• Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, et al.: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345, 725–30, 2001.
   PubMed Web of Science ®Google Scholar
• Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, et al.: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357, 1810–20, 2007.
   PubMed Web of Science ®Google Scholar
• Chinese Nutrition Society: Chinese Dietary Reference Intakes Handbook (2013). 1st ed. Beijing: China Standards Press, 2014.
   Google Scholar
• Zhu A, Kaneshiro M, and Kaunitz JD: Evaluation and treatment of iron deficiency Anemia: A gastroenterological perspective. Dig Dis Sci 55, 548–59, 2010.
   PubMed Web of Science ®Google Scholar
• Moon H, Roh J-L, Lee S-W, Kim S-B, Choi S-H, et al.: Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy. Radiother Oncol 118, 330–4, 2016.
   PubMed Web of Science ®Google Scholar
• Bae JM, Park JW, Yang HK, and Kim JP: Nutritional status of gastric cancer patients after total gastrectomy. World J Surg 22, 254–60; discussion 260–1, 1998.
   PubMed Web of Science ®Google Scholar
• Ohtsu A, Shah MA, Van Cutsem E, Rha SY, Sawaki A, et al.: Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol 29, 3968–76, 2011.
   PubMed Web of Science ®Google Scholar
• Ludwig H, Van Belle S, Barrett-Lee P, Birgegård G, Bokemeyer C, et al.: The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 40, 2293–306, 2004.
   PubMed Web of Science ®Google Scholar
• Park SH, Lee J, Lee SH, Park JO, Kim K, et al.: Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer. Cancer Chemother Pharmacol 57, 91–6, 2006.
   PubMed Web of Science ®Google Scholar
• Ji SH, Lim DH, Yi SY, Kim HS, Jun HJ, et al.: A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer. [Internet]. Vol. 9, BMC cancer 1102009, 2009.
   Google Scholar
• Caro JJ, Salas M, Ward A, and Goss G: Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 91, 2214–21, 2001.
   PubMed Web of Science ®Google Scholar
• Osterborg A, Brandberg Y, Molostova V, Iosava G, Abdulkadyrov K, et al.: Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies. J Clin Oncol 20, 2486–94 ST – Randomized, double – blind, placebo – co, 2002.
   PubMed Web of Science ®Google Scholar